Financhill
Back

Acacia Research Vs. Keros Therapeutics Industry Stock Comparison

Sell
38

ACTG
Acacia Research

Last Price:
5.01
Seasonality Move:
13.11%
Sell
27

KROS
Keros Therapeutics

Last Price:
45.71
Seasonality Move:
4.22%
Sell
38
Acacia Research (ACTG) is a Sell

Is Acacia Research a Buy, Sell or Hold?

  • The current Acacia Research [ACTG] share price is $5.01. The Score for ACTG is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • ACTG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics a Buy, Sell or Hold?

  • The current Keros Therapeutics [KROS] share price is $45.70. The Score for KROS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ACTG Stock Price Chart

What is Acacia Research's stock price today?

  • The Acacia Research share price today is $5.01
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACTG is experiencing buying pressure, which is a positive indicator for future bullish movement.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

  • The Keros Therapeutics share price today is $45.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight buying pressure.

ACTG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 41.09 Sell
Chaikin Money Flow: 172990 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.02 - 5.48) Sell
Bollinger Bands (100): (4.34 - 5.4) Buy

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.79 Sell
Relative Strength Index (14 RSI): 38.41 Sell
Chaikin Money Flow: 239305 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.72 - 49.1) Sell
Bollinger Bands (100): (49.87 - 64.91) Sell

ACTG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.99 Buy
20-day SMA: 5.18 Sell
50-day SMA: 5.19 Sell
200-day SMA: 4.3 Buy
8-day EMA: 5 Buy
20-day EMA: 5.12 Sell
50-day EMA: 5.12 Sell
200-day EMA: 4.57 Buy

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.61 Buy
20-day SMA: 47.29 Sell
50-day SMA: 51.65 Sell
200-day SMA: 47.07 Sell
8-day EMA: 45.93 Sell
20-day EMA: 47.34 Sell
50-day EMA: 50.89 Sell
200-day EMA: 50 Sell

Acacia Research Earnings Growth & ACTG Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.44 per share, and an increase next year of $0.25 per share.

Keros Therapeutics Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.

Acacia Research Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Keros Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):